DAPA-CKD: Significant Victory for CKD with or without Diabetes-MedSci.cn

DAPA-CKD: Significant Victory for CKD with or without Diabetes

Patel, AB; Mistry, K; Verma, A

Patel, AB; Verma, A (corresponding author), Brigham & Womens Hosp, Renal Div, 75 Francis St, Boston, MA 02115 USA.; Patel, AB; Verma, A (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021; 32 (6): 335

Abstract

Sodium glucose cotransporter 2 inhibitors (SGLT2i) have revolutionized the treatment of heart failure and diabetic kidney disease. The DAPA-CKD trial ......

Full Text Link